WO2003106702A1 - グルコース脱水素酵素を用いたグルコース濃度測定方法およびグルコースセンサ - Google Patents
グルコース脱水素酵素を用いたグルコース濃度測定方法およびグルコースセンサ Download PDFInfo
- Publication number
- WO2003106702A1 WO2003106702A1 PCT/JP2003/007630 JP0307630W WO03106702A1 WO 2003106702 A1 WO2003106702 A1 WO 2003106702A1 JP 0307630 W JP0307630 W JP 0307630W WO 03106702 A1 WO03106702 A1 WO 03106702A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glucose
- enzyme
- reagent layer
- sensor according
- concentration
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
Definitions
- the present invention relates to a technique for measuring the concentration of glucose in a sample solution (for example, a biochemical sample such as blood or a preparation thereof).
- a sample solution for example, a biochemical sample such as blood or a preparation thereof.
- ⁇ attach a glucose sensor that performs an enzyme reaction field to the blood glucose measuring device and supply blood (specimen) to the gnorecose sensor.
- the blood glucose level is measured.
- a method of incising the skin of the measurer to collect blood and supplying the blood night as a sample night to a glucose sensor is generally adopted.
- the amount of blood to be collected is smaller, so various improvements have been made so that the blood glucose level can be measured with a smaller amount of blood (sample). ; ⁇ Under consideration.
- the glucose sensor has, for example, a structure in which a reagent layer is formed on a substrate, and a cabillary is provided with the reagent layer contained therein (see FIGS. 2 and 3).
- the reagent layer is composed of a substance containing an oxidoreductase and an electron transfer substance. GOD and PQQGDH are used as oxidoreductases. Published 2000-65778).
- a liquid-phase reaction system is built inside the capillary. At this time, for example, the oxidation reaction of glucose is catalyzed by the oxidoreductase, while the reduction reaction of the electron mediator is performed. The reaction is catalyzed.
- the response current value is measured by applying «! To the reaction system using the electrodes of the gnorecose sensor as IJ.
- This response current value is caused, for example, by the amount of the reduced electron mediator (the amount correlated with the glucose concentration), and is the basis for calculating the glucose concentration.
- the glucose concentration is calculated; the coulometry method or the averometry method is used for ⁇ .
- the coulometric method is a method of reacting almost all glucose in a sample, obtaining an integrated value of a response current value for calculation, and calculating a glucose concentration based on the integrated value (coulomb).
- the averometry method is a method in which a response current value is obtained after a certain time from the start of the reaction, and the glucose concentration is calculated based on the response current value.
- GOD has a low rate of reaction with glucose (Km (Michaelis female) is large), so the coulometric method, in which most of the glucose in the sample is reacted to obtain a coulomb for calculation, significantly increases the measurement time.
- Km Meichaelis female
- the coulometric method in which most of the glucose in the sample is reacted to obtain a coulomb for calculation, significantly increases the measurement time.
- the umbellometry method is used.
- the averometry method has a small measurement range and is not suitable for the measurement of a small amount of sample.
- GOD is not very reactive with electron mediators. Therefore, in order to shorten the measurement time, it is necessary to use a large amount of electron mediator. as a result, It becomes difficult to reduce the size of W glucose sensors (more precisely, reagent layers and cavities), and accordingly the required sample volume also increases. From this point, it can be said that the method using GOD is not suitable for measuring a small amount of a sample.
- the amount of a sample that can accurately measure dulcose is 0.6 L at minimum, 15 seconds at minimum in measurement time, and gnorecose concentration in measurement range.
- the range of 10 to 600 mg / dL is the limit.
- the use of the coulometric method for the use of PQQGDH as an oxidoreductase makes it possible to measure blood glucose even with a small sample of 0.3 L.
- the coulometric method is a method of calculating the glucose concentration using almost all glucose in a sample as described above, and thus the measurement time is relatively higher in a high glucose concentration region than in the amperometric method. Tends to be longer. For example, to secure the minimum measurement range (10 to 600 mg / dL) required for practical use, it is necessary to secure a measurement time of 15 to 30 seconds.
- An object of the present invention is to make it possible to measure a small amount of a sample with high accuracy in a short time while securing a large measurement range.
- a reaction system including an enzyme and an electron mediator is used.
- cytochrome C it is preferable to use those derived from microorganisms belonging to the genus Burkholderia.
- the cytochrome C one having a molecular weight of about 43 kDa can be used, as determined by SDS-polyacrylamide gel electrophoresis in reducing conditions.
- a method for measuring glucose concentration using a reaction system containing an enzyme and an electron mediator wherein a glucose enzyme derived from the genus Burkholderia is used as the enzyme.
- a glucose concentration measuring method using a glucose ⁇ enzyme is used, wherein a Ru compound is used as the electron mediator.
- a stimulus is given to the reaction system, while a response to the stimulus is detected, and the glucose concentration is calculated based on the detected amount of the response.
- the stimulus is given as, for example, and the response is obtained as a current or optical property.
- a reaction system is provided by providing a first solution and a second solution, and a layer containing an enzyme and an electron transfer substance, and supplying a glucose solution to the reagent layer.
- a glucose sensor configured to apply a stimulus to the reaction system using the first and second electrodes, wherein a glucose enzyme to which cytochrome C is bound is used as the enzyme;
- Glucose sensors are known, which use a Ru compound as the electron mediator.
- cytochrome C it is preferable to use those derived from microorganisms belonging to the genus Burkholderia.
- cytochrome C those having a molecular weight S of about 43 kDa can be used, as determined by SDS-polyacrylamide gel electrophoresis in reducing gel.
- a first and a second electrode and a reagent layer containing an enzyme and an electron transfer substance, and a glucose solution is supplied to the reagent layer to construct a reaction system.
- a glucose sensor configured to apply a stimulus to the reaction system using the first and second electrodes, wherein a glucose!
- a glucose sensor is a glucose sensor in which a Ru compound is used as the electron mediator and a glue layer is used.
- the glucose ⁇ enzyme has glucose fck enzyme activity, and has a molecular weight of about
- the glucose dehydrogenase may have a ⁇ -subunit having a molecular weight of about 14 kDa in SDS-polyacrylamide gel electrophoresis under reducing conditions.
- a complex represented by the following chemical formula can be used as the Ru compound.
- X in the above chemical formula includes NH 3 , a halogen ion, CN, pyridine, nicotinamide, or 0. Of those exemplified, it is preferable to use a Ru complex in which X is NH 3 or a halogen ion. On the other hand, n + in the chemical formula indicates the valency of the Ru complex determined by the type of X.
- the Ru complex usually exists as an oxidized form ( ⁇ ) because the reduced form ( ⁇ ) is unstable. Therefore, for example, even when exposed to light or water with the oxidized Ru complex mixed in the reagent layer of the glucose sensor, it is not easily reduced. Further, the Ru complex is unlikely to be crystallized, and has a remarkable property if the fine powder state can be appropriately maintained. From this point, it can be said that the Ru complex has high solubility. Therefore, it is preferable to include a Ru complex as an oxidized type in the ⁇ reagent layer in consideration of exposure resistance, storage stability, and the like.
- the glucose sensor of the present invention is provided with, for example, a reagent layer, and is further provided with a liquid holding space for storing a captive sample solution.
- the reagent layer is configured as a solid layer, and is configured such that at least a part of the oxidoreductase and the electron transfer substance dissolve in the sample liquid when the sample liquid is held in the liquid holding space.
- the glucose sensor be configured such that after the sample supply, a reaction system is formed as a liquid phase by the glucose, the oxidoreductase, and the electron transfer substance in the liquid holding space.
- the volume of the liquid space is set to, for example, 0.1 to 0.5 L so that a small amount of sample solution can be measured.
- the content of the oxidoreductase in the reagent layer is, for example, an amount corresponding to 1.0 to 10.0 U of glucose enzyme activity. 1 unit of enzyme (U) Under constant conditions (pH 6.0, 37 ° C), the fading based on the reduction of DCIP (2,6-dichroic phenol-indolephenol) is reduced to 600nm, the absorption wavelength of DCIP! It was defined as the amount that oxidizes 1 ⁇ of glucose every minute (molar extinction coefficient is 4 ⁇ 76 ⁇ 1000 M / cm) when measured periodically.
- the content of the electron mediator in the reagent layer is, for example, 1.0 to 5.0 wt% corresponding to the concentration of the electron mediator when filled with the liquid holding space force S sample solution. Is done.
- the liquid space is configured to move the sample liquid by, for example, capillary force.
- a microorganism belonging to the genus Burkholderia produces an enzyme containing ⁇ -subunit having glucose enzyme activity or cytochrome C (] 3 subunit) (hereinafter sometimes simply referred to as “GDH”).
- GDH cytochrome C
- Burkholderia 'Sepathia especially Burkholderia' Sepathia KS1 strain (hereinafter sometimes simply referred to as “KS1 strain”) is preferable.
- the KS1 strain is a new strain isolated from soil strength near ⁇ , but it has been identified as Burkholderia sepacia based on its microbiological properties, and the industrial technology was established on September 25, 2000. It has been deposited as a microorganism accession number ⁇ FERM BP-7306 at the National Institute for Patent Organism Depositary (1-1, Higashi 1-1, Tsukuba, Ibaraki, 305-8566, Japan).
- the KS1 strain can produce GDH containing a submit (molecular weight of about 60 kDa), ⁇ submit (corresponding to cytochrome C) (molecular weight of about 43 kDa) and ⁇ submit (molecular weight of about 14 kDa). However, the molecular weight was measured by SDS-polyacrylamide gel electrophoresis under reducing conditions.
- Cytochrome C (including submit) is an electron transfer protein, and binds cytochrome C to a subunit (including ⁇ - subunit) having glucose dehydrogenase activity from the viewpoint of improving the electron transfer rate. It is preferable to use it as a GDH (hereinafter sometimes simply referred to as “CyGDH”). Cytochromes are not limited to those derived from microorganisms belonging to the genus Burkholderia (j3 subunit), but also bind to subunits that have glucose J! Finally, it may be derived from other microorganisms or living cells.
- the ⁇ -subunit has glucose dehydrogenase activity as described above.
- GDH that is powerful with ⁇ -subunit and ⁇ -subunit (hereinafter simply referred to as “GDHJ” Has a higher reaction rate with glucose (greater Vmax / Km) than GDm without the ⁇ subunit. This point is ⁇ by the present inventors. Therefore, from the viewpoint of increasing the rate of reaction with glucose, it is preferable to use DHsubunit in combination with ⁇ ⁇ subunit and use it as GDH in the case of using ⁇ subunit.
- FIG. 1 shows a state in which a glucose sensor according to the present invention is mounted on a concentration measuring device.
- FIG. 1 is a block diagram of the concentration measuring device, and a plan view of the glucose sensor. .
- FIG. 2 is an overall perspective view showing an example of the glucose sensor.
- FIG. 3 is an exploded perspective view of the glucose sensor of FIG.
- FIG. 4 is a graph showing an example of a voltage value applied between the first and second electrodes and a response current value over time in the measurement of glucose concentration.
- FIG. 5 is a graph showing another example of the voltage value applied between the first and second electrodes and the response current value over time in measuring the glucose concentration.
- Figures 6 6 to 6D are graphs showing the relationship between the concentration of Darcos and the response current 5 seconds after the start of the reaction. It is.
- FIGS. 7A to 7D are graphs showing the relationship between the Darcos concentration and the response current value 5 seconds after the start of the reaction when the reagent layer was formed using an iron complex.
- FIGS. 8A to 8D are graphs showing the relationship between the concentration of Darcos and the response current 10 seconds after the start of the reaction when the reagent layer is formed using a Ru complex.
- FIGS. 9A to 9D are graphs showing the relationship between the concentration of Darcos and the response current 10 seconds after the start of the reaction when the reagent layer is formed using an iron complex.
- FIGS. 10A to 10D are graphs in which the effect of hematocrit (Hct) is evaluated as Bias (based on Hct 42%) after a specific time has elapsed from the start of the reaction.
- Hct hematocrit
- the concentration measuring device 1 shown in FIG. 1 is for measuring the concentration of gnorecose in a sample solution containing gnorecose such as blood using the glucose sensor 2 according to the present invention.
- the concentration measuring device 1 is generally configured to include a voltage applying unit 3, a current value measuring unit 4, a detecting unit 5, a control unit 6, a calculating unit 7, and a display unit 8.
- the glucose sensor 2 is configured to be used and discarded, and has a cover plate 20, a spacer 21 and an anti-22 as best seen in FIGS.
- the cover plate 20 is provided with a hole 23, and the spacer 21 is provided with a narrow slit 24 communicating with the hole 23 and having an open end 24a.
- key Yabirari 25 is defined by the slit 24.
- the capacity of the capillaries 25 is set to, for example, 0.1 to 0.5 ⁇ L, and the capillaries 25 communicate with the outside via the opening 24 a at the tip of the slit 24 and the hole 23.
- the distal end opening 24a forms a sample liquid inlet 25a, and the supplied sample liquid flows through the capillaries 25 ⁇ toward the hole 23 by capillary action. I do.
- a first electrode 26, a second preparation 27, and a drug layer 28 are provided on an upper surface 22 a of the substrate 22.
- the first and second layers 26 and 27 extend in the longitudinal direction of the screen 22 as a whole, and their ends 26 a and 27 a extend in the lateral direction of the substrate 22.
- the upper surface 22a of the substrate 22 is covered with an insulating film 29 so that the ends 26a, 26b, 27a, 27b of the first and second electrodes 26, 27 are exposed.
- the reagent layer 28 is, for example, in a solid state, and ends 26 a, 27 of the first and second electrodes 26, 27. It is provided so as to bridge between a.
- the reagent layer 28 contains, for example, a relatively large amount of oxidized Ru compound (electron mediator) and a relatively small amount of GDH (glucose dehydrogenase).
- the content of GDH in the reagent layer is, for example, an amount corresponding to the glucose enzyme activity of 1.0 to 10.0 U, and the content of the Ru compound in the reagent layer is, for example, that the capillaries 25 are filled with the sample solution.
- the concentration of the Ru compound at that time is 1.0 to 5. ( ⁇ %).
- the oxidized Ru compound may function as an electron carrier.
- a Ru complex represented by the following chemical formula.
- Examples of X in the above formula include NH 3 , a halogen ion, CN, pyridine, nicotinamide, and 3 ⁇ 40. Of those exemplified, it is preferable to use a Ru complex in which X is NH 3 or a halogen ion. On the other hand, n + in the ⁇ ⁇ formula indicates the valency of the Ru complex determined by X.
- the ratio of the Ru compound to GDH is increased, and the Ru compound has a large effect on the solubility of the reagent layer 28.
- a Ru complex represented by a chemical formula as a Ru compound is difficult to be crystallized, can appropriately maintain a fine powder state, and has high solubility. Therefore, the reagent layer 28 has a high melting angle needle as a whole, and is easily dissolved by supplying blood. Therefore, even if the volume of the capillary 25 is set to be small as in the above-described range, the Gunorecose sensor 2 can appropriately provide a substantially homogeneous liquid-phase reaction system in the capillary 25 mm when blood is supplied. It can be built.
- GDH it is preferable to use a substance in which cytoplasm M, an electron transfer protein, is bound to a subunit having glucose enzymatic activity.
- the subunit cytochrome C having glucose enzymatic activity for example, a microorganism belonging to the genus Purkholderia, for example, a microorganism derived from the strain Burkholderia cepacia KS1.
- subunit cytochrome C having glucose dehydrogenase activity is not limited to microorganisms belonging to the genus Burkholderia, but may be derived from other microorganisms or living cells as long as the desired function can be exhibited.
- the expression code of the target subunit is Burkholderia
- the vector may be obtained from a microorganism belonging to the above, and also transduced into the host with a setter containing the expression code and produced from the host.
- the submitt with glucose enzymatic activity is obtained as an ⁇ -subunit with a molecular weight of 60 kDa
- cytochrome C is obtained as a ⁇ -subunit with a molecular weight of 43 kDa.
- This KS1 strain produces GDH in which 0 / subunit, a molecule of 4 ⁇ 14 kDa, is bound to the 3 ⁇ 4 subunit and the / 3 subunit.
- the molecular weight is determined by SDS-polyacrylamide under reducing conditions.
- aGDH in which ⁇ -subunit is bound to c-subunit.
- CyGDH in which a subunit (cytochrome C) is bonded to aGDH.
- the mil application section 3 shown in FIG. 1 applies a constant voltage between the end 26 b of the first electrode 26 and
- 3 ⁇ 4 ⁇ Applying section 3 attaches glucose sensor 2 to an attaching section (not shown) provided in glucose concentration measuring device 1, so that glucose sensor 2 can be connected via first and second worms 3 a and 3 b. It is designed to be electrically connected to the ends 26 b and 27 b of the no-coordinate sensor 2.
- a direct current source such as a dry battery or a rechargeable battery is used.
- the current value measuring unit 4 measures a response current value that is correlated with the amount of electrons emitted from, for example, a reduced Ru compound when a shield is applied to the reaction system.
- the detection unit 5 detects whether or not the sample liquid is supplied to the reagent layer 28 after the glucose sensor 2 is mounted on the glucose concentration measuring device 1 and the glucose concentration can be measured.
- the control unit 6 controls the application unit 3 to select a state in which E is applied between the first and second electrodes 26 and 27 (closed circuit) and a state in which E is not applied (open circuit). .
- the calculating unit 7 calculates the glucose concentration in the sample liquid according to the response current value measured by the current value measuring unit 4.
- each of the detection unit 5, the control unit 6, and the calculation unit 7 is a total of the force detection unit 5, the control unit 6, and the calculation unit 7 configured by, for example, a CPU and a memory such as a memory. It is also possible to configure by connecting multiple memories to one CPU.
- the calculation result by the calculation unit 7 is displayed on the display unit 8.
- the display unit 8 is composed of, for example, an LCD.
- the glucose sensor 2 is set in the glucose concentration measuring device 1. Then, the body 6 b of the first comforter 26 of the glucose sensor 2 is removed with the first insectworm 3 a of the concentration measuring device 1, and the end 27 b of the second electrode 27 is replaced with the second insectworm 3 b. Remove the insects. As mentioned earlier, in this state, the first and second i-lines 26 and 27 can conduct to the mis-applying section 3.
- the constant ME was set between the first and second comforters 26 and 27 by the application unit 3 under the control of the control unit 6 before the supply of the sample solution. Has been applied.
- the applied ⁇ value is set, for example, in the range of 100 to 500 mV.
- a sample liquid such as blood is supplied through the sample liquid inlet 25a of the gnorecourse sensor 2.
- the sample solution travels in the capillary 25 of the glucose sensor 2 by capillary action.
- the reagent layer 28 is dissolved by the sample liquid, and a liquid-phase reaction system is established.
- glucose is oxidized by GDH and the Ru compound is converted to a reduced form.
- the reduced Ru compound present in the reagent layer 28 is exposed to the end of the first electrode 26. It moves to the 26a side, and emits electrons to the end 26a to become an oxidized Ru compound. Therefore, when a constant mffi is supplied between the first and second electrodes 26 and 27 by the voltage applying unit 3, the amount of electrons provided from the reduced Ru compound is reduced by the first electrode 26 and the first worms 3 The current is measured as a response current by the current value measurement unit 4 via a.
- the response current value measured by the current value measurement unit 4 is monitored by the detection unit 5, and as shown in FIG. 4, the response 3 ⁇ 4 ⁇ value is changed to the threshold value I (for example, 0.1 to 3.0).
- the detection unit 5 detects that the sample liquid is supplied to the reagent layer 28 and the reagent layer 28 is dissolved.
- Part 4 is constant from the detection time (e.g., 1 2 -. T 10 seconds or less, more preferably less than 5 seconds) to measure the response current value 1 2 for operation at the elapsed point 2.
- a certain period of time (for example, one t. Is 10 seconds or less, and more preferably 3 seconds or less) is detected after the detection unit 5 detects that the sample liquid is supplied. Until the time point ti elapses, the mika-noodles may be discontinued. On top of that, while reapplying the Mffi from time 1 1, a predetermined time after the re-application (e.g. t - ti is 3 seconds or more, more preferably 3 seconds to 5 seconds) the response current at the time t 2 which has passed the value may be the adopted as a response current value 1 2 for operation.
- a predetermined time after the re-application e.g. t - ti is 3 seconds or more, more preferably 3 seconds to 5 seconds
- the response current at the time t 2 which has passed the value may be the adopted as a response current value 1 2 for operation.
- the computing unit 7 computes the gnorecose concentration in the sample solution based on the response current for computation.
- the response current value is converted to a mm value, and then the ⁇ value is calculated.
- the calculation is performed by applying a previously created calibration curve indicating the relationship between the HE value and the glucose concentration, and the calibration curve is stored in the ROM together with a program for converting the data into data and shearing the calculation. .
- the reagent layer 28 is configured by combining a Ru compound and a specific GDH (o; GDH, CyGDH, or the like).
- the reaction rate (including both the enzyme reaction rate and the electron transfer rate (Vmax / Km)) when the sample solution is supplied is large.
- Vmax / Km is about 2100. is there. Therefore, even when the concentration of gnorecose is low, the glucose reaction force S progresses at the maximum speed, and the amount of the reaction product generated per unit time is the same regardless of the glucose concentration.
- the reaction system can be constructed in a substantially uniform liquid phase. Therefore, even when blood (sample) is used as a sample liquid, the response current value can be measured with good reproducibility without being significantly affected by blood cell components.
- the biosensor using the Ru compound Since Ru compounds such as Ru complexes are stable in the oxidized form and therefore difficult to convert to the reduced form, the biosensor using the Ru compound has high storage stability and a small backround. For this reason, even if the glucose concentration is low and the glucose concentration is measured using a sample or a trace amount of sample, the measurement accuracy may not be reduced.
- the glucose concentration measuring method has been described in combination with a glucose sensor and a concentration measuring device.
- the glucose concentration measuring method according to the present invention uses a meter provided with an enzyme-immobilized electrode! / It is also possible to realize this.
- a glucose sensor composed of a reagent layer by combining Ru complex and GDH or CyGDH has a high reaction rate (a short measurement time) even for a trace amount of analyte. ), Demonstrate that the measurement range is wide and excellent in reproducibility, and that it is not easily affected by hematocrit (Hct).
- the glucose sensor As the glucose sensor, a sensor with a first electrode, a second electrode, a reagent layer, and a capillary formed on the grave (see Figs. 2 and 3) was used.
- the first and second electrodes were formed by screen printing a carbon ink thereon and then drying.
- the volume of the capillaries was basically set at 0.3. However, as for the effect of Hct in the specimen, we examined the case where the volume of capillaries was 0.4 L and 0.5 At L, as described later.
- the reagent layer had a two-layer structure including an electron transfer layer and an enzyme-containing layer.
- the electron transfer layer was formed by applying 0.4 ⁇ L of the first material liquid containing the electron transfer substance on the substrate, and then blowing and drying the first material liquid (30 ° C., 10% Rh).
- the fermentation layer was formed by applying a second material liquid 0.3 containing oxidoreductase on the electron transport layer, and then drying the second material liquid with air (30. C, 10% Rh).
- the first material liquid was prepared by mixing a liquid mixture obtained by mixing 1 to 1 of Table 1 in the following order in the order of 1 to 3 days, and then adding an electron transfer substance to the mixed liquid. No. 2
- the material solution was prepared by dissolving oxidoreductase in 0.1% CHAPS.
- Table 1 Composition of the first material liquid (excluding electron mediator) In Table 1, etc., S ⁇ is an abbreviation for Lucent Tight SW, and CHAPS is
- 3- [(3- cholamidopropy ⁇ ) dimethylammonio] is an abbreviation for propanesulfonic acid, and is an abbreviation for ACESf ⁇ N- (2-acetamido) -2-aminoetanesulfonic acid.
- the SWN used was “3150” manufactured by Corp Chemical Co., Ltd.
- the CHAPS used was “KC062” manufactured by Dojinka ⁇ 1 Kissho
- the ACES used was “ED067” manufactured by Dojinka ⁇ f Kissho.
- the ACES solution was prepared to have a pH of 5.
- ⁇ ⁇ (sample) whose glucose concentration and Hct value were adjusted to target concentrations was used. Hct values are adjusted to 42% unless otherwise specified.
- the glucose concentration was adjusted to 103 ⁇ g / dL for the 0, 101, 412, 624, and 820 levels depending on the purpose of the test.
- the response current value was determined by applying a constant potential (200 mV) between the first and second electrodes of the glucose sensor to the reagent layer in an amount corresponding to the capacity of the capillary (0.3 ⁇ m ⁇ , 0.5 ⁇ m).
- the sample of L) was supplied, and measurement was performed after a lapse of a specified time (10 seconds for 5 seconds). [Evaluation of measurement range]
- the measurement range was determined by measuring the response current value using samples with various glucose concentrations and plotting the plot points when the glucose concentration was set on the horizontal axis and the response current value was set on the vertical axis.
- FIGS. 9A to 9D show the results for the response current value 10 seconds after the sample supply.
- each plot point is shown as an average value after measuring the response current values for 10 gnorecourse sensors that were made the same.
- the oxidoreductase and electron mediator were as shown in Table 2 below.
- sensor numbers A-1 to B-3 and B-1 to B-3 are the DLC sensors of the present invention, and the others are glucose sensors for comparison.
- the activity of oxidoreductase in Table 2 indicates the activity in the liquid phase reaction system when a sample is supplied to the capillaries to form a liquid phase reaction system. It shows the weight ratio of the electron transfer substance in the liquid phase reaction system.
- the effect of Hct is to measure the response current value after a lapse of a certain period of time from the supply of samples using multiple samples with the same glucose concentration and different Hct values for multiple gnorecoses with the same reagent layer composition.
- the glucose sensor sensors 1 to 3 of the present invention and a comparison sensor were used.
- the capillary volume is set to 0.5 with the spacer thickness of 58 ⁇ m
- the capillary volume is set with the spacer thickness of 44 ⁇ m.
- FIGS. 10A to 10C The results when using the sensors 1 to 3 of the present invention are shown in FIGS. 10A to 10C, and the results when using the comparative sensor are shown in FIG. 10D.
- the response current value when the Hct value is 42% is used as a reference, and the amount of deviation (Bias) from the measured value is shown on the vertical axis.
- the horizontal axis represents time
- the horizontal axis represents Hct values.
- Each plot point in each figure is shown as an average value of five measurements, and each plot point in FIG. 10D is calculated based on the value 30 seconds after the supply of the sample.
- the glucose sensor combining aGDH and Ru complex requires less glucose (2 wt%) to achieve higher glucose content.
- gnorecose sensors E-1 to 3, F-1 to 3, G_3 to 3, Hl to 3 using Ferri as the electron mediator are shown in Figs. 7A to 7D and 9A to 9A.
- D 3 ⁇ 4
- the amount of enzyme is larger in the gnorecose sensors G-1-3 and Hl-3 using PQQGDH as the oxidoreductase.
- the reaction rate of a system in which Ru and CyGDH are combined is inferior to the reaction rate, and is not practical.
- Tables 3 to 8 the solubility of Ferri itself is poor, and the overall reproducibility is poor. From this point of view, practicality is lacking.
- the comparative sensor is greatly affected by Hct even if the Hct value is large even after 30 seconds from the start of sample supply, and its Bias value is equivalent to the 5-second value of the sensor of the present invention. It is about. Therefore, the sensor of the present invention combining Ru complex and CyGDH:! To 3 can be measured in a short time even with a small amount of sample, and is not easily affected by Hct. Therefore, the combination of the Ru complex and CyGDH can reduce the amount of the sample and the measurement time, and can construct a glucose sensor that is hardly affected by Hct.
- the measurement range is increased by constructing a reaction system in which a Ru complex is combined with a specific glucose dehydrogenase (cytochrome C bound or derived from a microorganism belonging to the genus Burkholderia). It is possible to measure a small amount of glucose and venom at a high accuracy, in a short time and with high accuracy, without much influence of hematocrit.
- a specific glucose dehydrogenase cytochrome C bound or derived from a microorganism belonging to the genus Burkholderia
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN03814252XA CN1662660A (zh) | 2002-06-17 | 2003-06-16 | 使用葡萄糖脱氢酶的葡萄糖浓度测定方法及葡萄糖传感器 |
EP03733454A EP1522592B1 (en) | 2002-06-17 | 2003-06-16 | Glucose sensor with the use of glucose dehydrogenase |
US10/518,858 US7341846B2 (en) | 2002-06-17 | 2003-06-16 | Method of measuring glucose concentration and glucose sensor with the use of glucose dehydrogenase |
KR1020047020491A KR100729307B1 (ko) | 2002-06-17 | 2003-06-16 | 글루코스 탈수소효소를 이용한 글루코스 농도 측정방법 및글루코스 센서 |
DE60322708T DE60322708D1 (de) | 2002-06-17 | 2003-06-16 | Glucosesensor unter verwendung von glucosedehydrogenase |
JP2004513514A JP4621841B2 (ja) | 2002-06-17 | 2003-06-16 | グルコース脱水素酵素を用いたグルコース濃度測定方法およびグルコースセンサ |
AU2003241683A AU2003241683A1 (en) | 2002-06-17 | 2003-06-16 | Method of measuring glucose concentration and glucose sensor with the use of glucose dehydrogenase |
US12/008,358 US7824881B2 (en) | 2002-06-17 | 2008-01-10 | Glucose level measuring method and glucose sensor utilizing glucose dehydrogenase |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-176368 | 2002-06-17 | ||
JP2002176368 | 2002-06-17 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10518858 A-371-Of-International | 2003-06-16 | ||
US12/008,358 Division US7824881B2 (en) | 2002-06-17 | 2008-01-10 | Glucose level measuring method and glucose sensor utilizing glucose dehydrogenase |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003106702A1 true WO2003106702A1 (ja) | 2003-12-24 |
Family
ID=29728091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/007630 WO2003106702A1 (ja) | 2002-06-17 | 2003-06-16 | グルコース脱水素酵素を用いたグルコース濃度測定方法およびグルコースセンサ |
Country Status (9)
Country | Link |
---|---|
US (2) | US7341846B2 (ja) |
EP (1) | EP1522592B1 (ja) |
JP (1) | JP4621841B2 (ja) |
KR (1) | KR100729307B1 (ja) |
CN (2) | CN102533939B (ja) |
AT (1) | ATE403742T1 (ja) |
AU (1) | AU2003241683A1 (ja) |
DE (1) | DE60322708D1 (ja) |
WO (1) | WO2003106702A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006123730A1 (ja) * | 2005-05-20 | 2006-11-23 | Arkray, Inc. | タンパク質固定膜、タンパク質の固定化方法、酵素固定化電極、およびバイオセンサ |
JP2009520792A (ja) * | 2005-12-21 | 2009-05-28 | オックスフォード バイオセンサーズ リミテッド | レドックスメディエータ |
JP2012132926A (ja) * | 2009-04-30 | 2012-07-12 | Ikeda Shokken Kk | 蛋白質性電子メディエータ |
CN102639997A (zh) * | 2009-12-11 | 2012-08-15 | 霍夫曼-拉罗奇有限公司 | 用于测试元件的稳定化学作用 |
JPWO2014002999A1 (ja) * | 2012-06-25 | 2016-06-02 | 合同会社バイオエンジニアリング研究所 | 酵素電極 |
WO2023074454A1 (ja) | 2021-10-28 | 2023-05-04 | パナソニックIpマネジメント株式会社 | 酸化還元酵素及び補酵素を含む反応系を用いた処理装置並びにその制御方法 |
WO2023074455A1 (ja) | 2021-10-28 | 2023-05-04 | パナソニックIpマネジメント株式会社 | 処理装置の制御方法、酵素電極及び処理装置 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003289373A1 (en) * | 2002-12-20 | 2004-07-29 | Arkray, Inc. | Thin analyzing device |
US7497940B2 (en) * | 2003-09-02 | 2009-03-03 | Koji Sode | Glucose sensor and glucose level measuring apparatus |
JP2007197297A (ja) * | 2005-12-27 | 2007-08-09 | Canon Inc | 多孔体、多孔体を含む組成物及び多孔体を備えるセンサー |
WO2008040984A1 (en) | 2006-10-05 | 2008-04-10 | Lifescan Scotland Limited | A reagent formulation using ruthenium hexamine as a mediator for electrochemical test strips |
JP2010510517A (ja) * | 2006-11-20 | 2010-04-02 | バイエル・ヘルスケア・エルエルシー | 試験センサカートリッジ |
US8101062B2 (en) | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
US20090076738A1 (en) * | 2007-07-26 | 2009-03-19 | Ferhan Kayihan | System and Methods for Determination of Analyte Concentration Using Time Resolved Amperometry |
KR101103682B1 (ko) * | 2008-04-08 | 2012-01-11 | 주식회사 올메디쿠스 | 바이오센서 |
KR101107506B1 (ko) | 2011-09-08 | 2012-01-31 | 한국지질자원연구원 | 이산화티타늄-그래핀 복합체가 구비된 글루코스 센서 |
KR102347669B1 (ko) | 2014-03-28 | 2022-01-07 | 에스케이이노베이션 주식회사 | 이중 전극쌍을 이용한 전기화학 바이오 센서 |
KR101880206B1 (ko) * | 2014-04-18 | 2018-07-20 | 도진도 래보라토리즈 | 탈수소 효소 및 이의 기질 농도 측정 방법, 전자 메디에이터 및 상기 전자 메디에이터를 포함하는 탈수소 효소 및 이의 기질용 측정 시약 |
WO2019012865A1 (ja) * | 2017-07-14 | 2019-01-17 | テルモ株式会社 | 血糖値測定チップ及び血糖値測定装置セット |
CN108120794A (zh) * | 2017-12-21 | 2018-06-05 | 深圳市赛亿科技开发有限公司 | 一种智能杯子及其检测饮料中葡萄糖浓度的方法 |
US20220218239A1 (en) * | 2019-05-20 | 2022-07-14 | Sogang University Presearch Business Development Foundation | Electrochemical biosensor comprising carbon nanotube for measuring biosignals and method for manufacturing same |
US11536685B2 (en) | 2020-02-06 | 2022-12-27 | Trustees Of Boston University | High throughput assay for identifying microbial redox enzymes |
US11331020B2 (en) | 2020-02-06 | 2022-05-17 | Trustees Of Boston University | Enzyme-based electrochemical nicotine biosensor |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996039534A1 (en) * | 1995-06-06 | 1996-12-12 | Igen, Inc. | Electrochemiluminescent enzyme biosensors |
WO2002036779A1 (en) * | 2000-10-31 | 2002-05-10 | Koji Sode | Novel glucose dehydrogenase and process for producing the dehydrogenase |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3479522D1 (en) | 1983-12-16 | 1989-09-28 | Medisense Inc | Assay for nucleic acids |
US5205920A (en) * | 1989-03-03 | 1993-04-27 | Noboru Oyama | Enzyme sensor and method of manufacturing the same |
JP3267936B2 (ja) | 1998-08-26 | 2002-03-25 | 松下電器産業株式会社 | バイオセンサ |
EP1150118B1 (en) * | 1999-11-22 | 2005-02-09 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor and method for determining cholesterol |
US7390391B2 (en) | 2001-09-14 | 2008-06-24 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
-
2003
- 2003-06-16 JP JP2004513514A patent/JP4621841B2/ja not_active Expired - Lifetime
- 2003-06-16 AU AU2003241683A patent/AU2003241683A1/en not_active Abandoned
- 2003-06-16 CN CN201210001930XA patent/CN102533939B/zh not_active Expired - Lifetime
- 2003-06-16 AT AT03733454T patent/ATE403742T1/de not_active IP Right Cessation
- 2003-06-16 CN CN03814252XA patent/CN1662660A/zh active Pending
- 2003-06-16 EP EP03733454A patent/EP1522592B1/en not_active Expired - Lifetime
- 2003-06-16 KR KR1020047020491A patent/KR100729307B1/ko active IP Right Grant
- 2003-06-16 US US10/518,858 patent/US7341846B2/en not_active Expired - Lifetime
- 2003-06-16 WO PCT/JP2003/007630 patent/WO2003106702A1/ja active IP Right Grant
- 2003-06-16 DE DE60322708T patent/DE60322708D1/de not_active Expired - Lifetime
-
2008
- 2008-01-10 US US12/008,358 patent/US7824881B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996039534A1 (en) * | 1995-06-06 | 1996-12-12 | Igen, Inc. | Electrochemiluminescent enzyme biosensors |
WO2002036779A1 (en) * | 2000-10-31 | 2002-05-10 | Koji Sode | Novel glucose dehydrogenase and process for producing the dehydrogenase |
Non-Patent Citations (5)
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9702843B2 (en) | 2005-05-20 | 2017-07-11 | Arkray, Inc. | Biosensor incorporating protein-immobilized membrane and method of immobilizing protein in biosensor |
WO2006123730A1 (ja) * | 2005-05-20 | 2006-11-23 | Arkray, Inc. | タンパク質固定膜、タンパク質の固定化方法、酵素固定化電極、およびバイオセンサ |
JP2013079237A (ja) * | 2005-12-21 | 2013-05-02 | F Hoffmann-La Roche Ag | レドックスメディエータ |
JP2009520792A (ja) * | 2005-12-21 | 2009-05-28 | オックスフォード バイオセンサーズ リミテッド | レドックスメディエータ |
US8969025B2 (en) | 2009-04-30 | 2015-03-03 | Panasonic Healthcare Holdings Co., Ltd. | Protein electron mediator |
US8716442B2 (en) | 2009-04-30 | 2014-05-06 | Ikeda Food Research Co., Ltd. | Protein electron mediator |
JP2012132926A (ja) * | 2009-04-30 | 2012-07-12 | Ikeda Shokken Kk | 蛋白質性電子メディエータ |
CN102639997A (zh) * | 2009-12-11 | 2012-08-15 | 霍夫曼-拉罗奇有限公司 | 用于测试元件的稳定化学作用 |
US9399792B2 (en) | 2009-12-11 | 2016-07-26 | Roche Diabetes Care, Inc. | Sterilizable chemistry for test elements |
US10106835B2 (en) | 2009-12-11 | 2018-10-23 | Roche Diabetes Care, Inc. | Methods of producing sterilized diagnostic test elements |
JPWO2014002999A1 (ja) * | 2012-06-25 | 2016-06-02 | 合同会社バイオエンジニアリング研究所 | 酵素電極 |
WO2023074454A1 (ja) | 2021-10-28 | 2023-05-04 | パナソニックIpマネジメント株式会社 | 酸化還元酵素及び補酵素を含む反応系を用いた処理装置並びにその制御方法 |
WO2023074455A1 (ja) | 2021-10-28 | 2023-05-04 | パナソニックIpマネジメント株式会社 | 処理装置の制御方法、酵素電極及び処理装置 |
Also Published As
Publication number | Publication date |
---|---|
ATE403742T1 (de) | 2008-08-15 |
JP4621841B2 (ja) | 2011-01-26 |
AU2003241683A1 (en) | 2003-12-31 |
US7341846B2 (en) | 2008-03-11 |
EP1522592A4 (en) | 2006-07-19 |
DE60322708D1 (de) | 2008-09-18 |
JPWO2003106702A1 (ja) | 2005-10-13 |
US20060035300A1 (en) | 2006-02-16 |
US7824881B2 (en) | 2010-11-02 |
EP1522592A1 (en) | 2005-04-13 |
EP1522592B1 (en) | 2008-08-06 |
CN1662660A (zh) | 2005-08-31 |
US20080131919A1 (en) | 2008-06-05 |
KR100729307B1 (ko) | 2007-06-15 |
CN102533939B (zh) | 2013-11-20 |
KR20050019139A (ko) | 2005-02-28 |
CN102533939A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003106702A1 (ja) | グルコース脱水素酵素を用いたグルコース濃度測定方法およびグルコースセンサ | |
JP5044655B2 (ja) | 電気化学的テストストリップ用の伝達物質としてルテニウムヘキサミンを使用する試薬調合物 | |
JP7003103B2 (ja) | 干渉補償型の2電極テストストリップ | |
JP4352153B2 (ja) | 薄型分析用具 | |
CA2474912C (en) | Electrochemical biosensor strip for analysis of liquid samples | |
US20190249214A1 (en) | Test sensors and methods of using the same | |
JP4385219B2 (ja) | 濃度測定方法 | |
JP5453314B2 (ja) | 電気化学的検出に用いる改良型試薬組成物 | |
WO2005066638A1 (ja) | 試薬部の配置を改良した分析用具および分析方法 | |
Lee et al. | Biosensing and electrochemical properties of flavin adenine dinucleotide (FAD)-Dependent glucose dehydrogenase (GDH) fused to a gold binding peptide | |
ES2555215T3 (es) | Composiciones de reactivo de bajo contenido salino total y sistemas para biosensores | |
JP5380888B2 (ja) | グルコースの定量方法ならびに定量組成物 | |
US20220112536A1 (en) | Oxygen-insensitive electrochemical biosensor and methods of use thereof | |
JP2004317359A (ja) | バイオセンサおよび酵素保存方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004513514 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020047020491 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003814252X Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003733454 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020047020491 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003733454 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006035300 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10518858 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10518858 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003733454 Country of ref document: EP |